Fund Name | Location |
Abrams Capital | Boston, Massachusetts, United States |
Anhui Zhongding Sealing Parts | Anhui, China, Ningguo |
Compugen | Israel, Tel Aviv, Tel Aviv District |
GD10 Venture | - |
GENTOSHA MediaConsulting | Japan, Tokyo |
Hanhai Studio | Burbank, California, United States |
Heising-Simons Foundation | - |
Levine Leichtman Capital Partners | Beverly Hills, California, United States |
Medicis Pharmaceutical | Arizona, Scottsdale, United States |
NetApp | California, Sunnyvale, United States |
Novaquest Capital Management | North Carolina, Raleigh, United States |
o3 Capital | India, Maharashtra, Mumbai |
Pathfinder | California, San Francisco, United States |
RMKB Ventures | - |
Shanxi Heling Touzi guanli Co., Ltd. | China, Shaanxi, Xian Shi |
Squadron Medical Finance Solutions | - |
TenOneTen Ventures | California, Los Angeles, United States |
TinkBig Venture | Kuala Lumpur, Malaysia |
TVC | - |
Weiyin Fund Management | Beijing, Beijing, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.